Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengzhi is a diversified Chinese biotech and healthcare company with significant operations in clean energy, semiconductor materials, medical healthcare services, and life sciences. Its life science subsidiaries focus on the production of bio-sugars like D-ribose and amino acids via fermentation for use as food additives, nutraceuticals, or pharmaceutical intermediates. The company does not appear to have clinical-stage drug candidates but is an established supplier to the global health ingredient market
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengzhi.